In a cohort of 7 patients with DT2 and obesity, daily use of liraglutide 1.2mg achieved, after 10 weeks, a weight reduction of 5% and a decrease in BMI of 2kg/m2.80 In another study, 3 patients with DT2 and obesity achieved a decrease in BMI of between 0.8 and 3.8kg/m2 after 18 weeks with this same dose of liraglutide.81 Another 2 patients with obesity and DT2 achieved weight losses of more than 5kg and a decrease in BMI of 1.5 and 2kg/m2 after 6 weeks of treatment.82 Finally, in a series of 20 subjects with obesity and DT2, an average weight loss of 4.7kg was reported after 8 weeks of treatment with liraglutide 1.8mg.83 In most of these patients, improvements in the psoriasis area severity index (PASI) was observed, and on occasions, a decrease in psoriatic plaques
Zoungas S, Patel A, Chalmers J, et al
This increase was corroborated by elevated expression of aconitase and activity of succinate dehydrogenase (Krebs cycle enzymes), as well as increased activity of NADH dehydrogenase and expression of H-ATPase (oxidative phosphorylation enzymes)
Metabolism 92
We can help you understand how to get a replacement or adjust your schedule so you dont miss a beat